LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,098 | -12.3% | 47,596 | -12.3% | 0.00% | – |
| Q2 2023 | $179,120 | +54.2% | 54,279 | +58.5% | 0.00% | – |
| Q1 2023 | $116,127 | +94312.2% | 34,256 | 0.0% | 0.00% | – |
| Q4 2022 | $123 | -100.0% | 34,256 | +5.4% | 0.00% | – |
| Q3 2022 | $287,000 | +14.8% | 32,502 | 0.0% | 0.00% | – |
| Q2 2022 | $250,000 | -17.5% | 32,502 | +1.3% | 0.00% | – |
| Q1 2022 | $303,000 | +54.6% | 32,073 | +13.1% | 0.00% | – |
| Q4 2021 | $196,000 | -27.1% | 28,348 | -0.0% | 0.00% | – |
| Q3 2021 | $269,000 | +17.0% | 28,356 | +22.3% | 0.00% | – |
| Q2 2021 | $230,000 | -15.1% | 23,192 | 0.0% | 0.00% | – |
| Q1 2021 | $271,000 | -67.3% | 23,192 | 0.0% | 0.00% | – |
| Q4 2020 | $828,000 | +158.8% | 23,192 | 0.0% | 0.00% | – |
| Q3 2020 | $320,000 | -16.2% | 23,192 | 0.0% | 0.00% | – |
| Q2 2020 | $382,000 | +100.0% | 23,192 | +3.0% | 0.00% | – |
| Q1 2020 | $191,000 | – | 22,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 10,175 | $70,512,000 | 0.26% |
| Minerva Advisors LLC | 34,015 | $236,000 | 0.14% |
| Investors Financial Group, LLC | 30,600 | $212,000 | 0.10% |
| Lion Point Capital, LP | 51,205 | $354,000 | 0.10% |
| NEA Management Company, LLC | 376,916 | $2,612,000 | 0.05% |
| Wealth Advisors of Iowa, LLC | 11,699 | $81,000 | 0.04% |
| Paladin Advisory Group, LLC | 4,382 | $30,000 | 0.02% |
| Marquette Asset Management, LLC | 13,315 | $92,000 | 0.02% |
| Blackstone Inc. | 468,145 | $3,244,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $331,000 | 0.01% |